These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hormonal contraception]. Van Cauwenberge JR Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074 [TBL] [Abstract][Full Text] [Related]
3. [Morphofunctional features of the cervix uteri in women using hormonal contraception]. Prilepskaia VN; Kondrikov NI; Nazarova NM Akush Ginekol (Mosk); 1991 Dec; (12):6-10. PubMed ID: 1789353 [TBL] [Abstract][Full Text] [Related]
4. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones]. Farkas M Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635 [TBL] [Abstract][Full Text] [Related]
5. [Acceptability of hormonal contraceptives with a low steroid content]. Dubnitskaia LV Akush Ginekol (Mosk); 1988 Aug; (8):47-50. PubMed ID: 3195708 [TBL] [Abstract][Full Text] [Related]
12. [Internal medicine problems regarding contraception. Part I]. Mall-Haefeli M Schweiz Med Wochenschr; 1980 Sep; 110(36):1314-9. PubMed ID: 7444416 [TBL] [Abstract][Full Text] [Related]
13. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
14. Effect of switching with oral contraceptives. Wassef SA; Sami G; Hamid EA Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511 [TBL] [Abstract][Full Text] [Related]
15. [Hormonal contraception--side effects and surgical aspects (author's transl)]. Göretzlehner G; Carol W; Köhler G Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744 [TBL] [Abstract][Full Text] [Related]
16. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
17. [The choice of oral contraception in 1984: general indications and specific cases]. Gaspard U Rev Med Liege; 1984 Apr; 39(7):261-5. PubMed ID: 6729293 [TBL] [Abstract][Full Text] [Related]
18. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629 [TBL] [Abstract][Full Text] [Related]
19. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose. Karsay K Ther Hung; 1980; 28(1):17-20. PubMed ID: 7281074 [TBL] [Abstract][Full Text] [Related]